Risk of Hemolytic Uremic Syndrome Related to Treatment of Escherichia coli O157 Infection with Different Antimicrobial Classes

Treatment of Shiga toxin-producing Escherichia coli O157 (O157) diarrhea with antimicrobials might alter the risk of hemolytic uremic syndrome (HUS). However, full characterization of which antimicrobials might affect risk is lacking, particularly among adults. To inform clinical management, we cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Mody, Rajal K., Hoekstra, Robert M., Scott, Magdalena Kendall, Dunn, John, Smith, Kirk, Tobin-D’Angelo, Melissa, Shiferaw, Beletshachew, Wymore, Katie, Clogher, Paula, Palmer, Amanda, Comstock, Nicole, Burzlaff, Kari, Lathrop, Sarah, Hurd, Sharon, Griffin, Patricia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466573/
https://www.ncbi.nlm.nih.gov/pubmed/34576892
http://dx.doi.org/10.3390/microorganisms9091997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466573/
https://www.ncbi.nlm.nih.gov/pubmed/34576892
http://dx.doi.org/10.3390/microorganisms9091997

Ejemplares similares